MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

MIMEDX GROUP, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$4.38−0.05 (-1.13%)

Close on Oct 19, 2026

Market cap: $647.35M
P/E (TTM): 109.5
Dividend yield: –

MIMEDX GROUP, INC. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	166	104	82	66	87	96	69	45	27	30	26	47	44	6.75	4.11	1.34	2.65
Short-Term Investments	–	–	–	–	–	–	–	–	–	0	3.00	5.75	0	–	–	–	–
Cash & Short-Term Investments	166	104	82	66	87	96	69	45	27	30	29	52	44	6.75	4.11	1.34	2.65
Receivables	76	56	54	43	40	35	32	51	65	1.93	54	27	16	7.65	1.89	0.16	–
Inventory	25	24	21	13	11	10	9.10	16	9.47	16	7.46	5.13	3.88	3.02	0.71	0.11	–
Prepaid Expenses & Other	–	5.02	5.62	7.32	6.15	5.61	6.67	6.67	2.13	1.84	3.39	1.54	1.34	0.66	0.16	0.09	–
Other Current Assets	10	7.84	1.75	3.34	2.81	3.37	6.06	5.82	9.02	9.52	0.22	–	–	–	–	–	–
Total Current Assets	277	192	164	134	149	161	123	74	49	59	96	86	65	18	6.88	1.71	–
Property, Plant & Equipment	4.71	5.94	6.97	7.86	9.17	11	12	17	14	14	9.48	5.45	4.09	1.07	0.87	0.76	–
Gross Property, Plant & Equipment	–	–	–	–	–	41	36	35	26	22	14	8.95	6.39	3.35	2.68	–	–
Accumulated Depreciation	–	–	–	–	–	-29	-24	-18	-12	-8.51	-4.98	-3.50	-2.30	-2.28	-1.81	-1.39	–
Operating Lease Right-of-Use Assets	4.34	5.61	2.13	3.40	4.70	3.62	3.40	0	–	–	–	–	–	–	–	–	–
Goodwill	19	19	19	19	19	20	20	20	20	20	4.04	4.04	4.04	4.04	4.04	0.86	–
Intangible Assets	14	12	5.26	5.85	5.38	6.00	7.78	9.61	10	23	11	11	11	12	15	3.93	–
Deferred Tax Assets	20	28	41	0	–	–	–	0	26	0	15	–	–	–	–	–	–
Other Long-Term Assets	7.27	6.71	0.21	0.15	0.19	0.38	0.44	1.79	2.87	0.35	–	0	0	0.07	0.21	0.10	–
Total Assets	343	264	239	171	188	202	167	123	121	117	136	109	85	35	27	7.35	–
Accounts Payable	15	7.41	9.05	8.45	7.39	8.77	8.71	15	–	11	6.63	3.66	2.49	1.25	2.30	0.85	–
Accrued Expenses	11	9.01	9.36	11	9.81	30	32	32	16	19	4.64	2.50	1.41	0.99	0.78	–	–
Current Portion of Long-Term Debt	1.50	1.00	1.00	–	–	0	3.75	0	–	–	–	–	–	0	1.13	–	–
Current Debt	1.50	1.00	1.00	–	–	0	3.75	0	–	–	–	–	–	0	1.13	–	–
Current Portion of Leases	1.32	1.31	1.50	1.39	1.20	1.18	1.17	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	5.61	-0.07	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	0.56	0.55	–	–	–	–	–	–	–	–	–	–	–
Other Current Liabilities	5.79	4.51	2.89	1.83	1.57	1.47	1.40	1.82	0.65	1.48	0.53	0.72	0.12	0.02	0.01	–	–
Total Current Liabilities	64	46	46	44	42	59	67	72	46	61	27	18	9.61	5.02	4.73	1.25	–
Long-Term Debt	16	18	48	49	48	48	62	0	–	–	–	–	0	4.01	2.74	0	–
Long-Term Leases	3.25	4.71	0.89	2.38	3.81	2.96	2.92	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	4.57	6.01	2.39	3.77	5.02	4.14	4.09	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	–	–	1.13	–	–	–	–	–	–	–
Other Long-Term Liabilities	5.37	7.38	2.22	4.77	4.87	3.76	3.54	1.64	1.65	0.88	1.15	1.53	1.52	0.35	0.31	0	–
Total Liabilities	86	71	96	97	95	111	133	73	47	69	28	20	11	15	15	1.25	–
Total Debt	18	19	49	49	48	48	66	0	–	–	–	–	0	4.01	3.87	0	–
Preferred Stock	–	–	–	0	0	0	0	0	0	0	0	0	0	0	0	0	–
Common Stock	0.15	0.15	0.15	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.10	0.09	0.07	0.06	–
Additional Paid-In Capital	299	284	276	174	166	159	147	165	165	161	163	162	147	90	74	58	–
Retained Earnings	-43	-91	-134	-192	-162	-151	-102	-77	-47	-111	-38	-68	-74	-70	-62	-52	–
Treasury Stock	0	–	–	0	-4.02	-7.45	-11	-39	-44	-2.22	-17	-5.64	-0.03	-0.03	-0.03	-0.03	–
Shareholders' Equity	257	193	143	-18	0.08	-0.15	34	50	74	48	35	89	74	20	12	6.10	6.07
Total Equity	257	193	143	-18	0.08	-0.15	34	50	74	48	35	89	74	20	12	6.10	6.07
Total Liabilities & Equity	343	264	239	171	188	202	167	123	121	117	136	109	85	35	27	7.35	–
Shares Outstanding(shares)	148	147	146	114	112	111	111	109	109	110	107	108	104	88	74	64	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 78.8%
Operating margin: 2.5%
Net margin: 1.8%
Return on equity, FY2025: 21.6%

Financial strength

Current ratio: 5.33
Debt to equity: 0.08
Debt to assets: 6.1%
Cash to current liabilities: 352.8%

Valuation

P/E ratio: 109.5
Price to sales: 1.82
Price to book: 3.00
Dividend yield: –